Torres AG - Search Results

1

Development of Melioidosis Subunit Vaccines Using an Enzymatically Inactive Burkholderia pseudomallei AhpC.

Schmidt LK, Orne CE, Shaffer TL, Wilson SM, Khakhum N, Torres AG, Brett PJ, Burtnick MN. Schmidt LK, et al. Among authors: torres ag. Infect Immun. 2022 Aug 18;90(8):e0022222. doi: 10.1128/iai.00222-22. Epub 2022 Jul 11. Infect Immun. 2022. PMID: 35862715 Free PMC article.

2

Outer membrane protein A of Escherichia coli O157:H7 stimulates dendritic cell activation.

Torres AG, Li Y, Tutt CB, Xin L, Eaves-Pyles T, Soong L. Torres AG, et al. Infect Immun. 2006 May;74(5):2676-85. doi: 10.1128/IAI.74.5.2676-2685.2006. Infect Immun. 2006. PMID: 16622204 Free PMC article.

3

Host immunity in the protective response to vaccination with heat-killed Burkholderia mallei.

Whitlock GC, Lukaszewski RA, Judy BM, Paessler S, Torres AG, Estes DM. Whitlock GC, et al. Among authors: torres ag. BMC Immunol. 2008 Sep 29;9:55. doi: 10.1186/1471-2172-9-55. BMC Immunol. 2008. PMID: 18823549 Free PMC article.

4

Present and future therapeutic strategies for melioidosis and glanders.

Estes DM, Dow SW, Schweizer HP, Torres AG. Estes DM, et al. Among authors: torres ag. Expert Rev Anti Infect Ther. 2010 Mar;8(3):325-38. doi: 10.1586/eri.10.4. Expert Rev Anti Infect Ther. 2010. PMID: 20192686 Free PMC article.

5

Prophylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosis.

Judy BM, Taylor K, Deeraksa A, Johnston RK, Endsley JJ, Vijayakumar S, Aronson JF, Estes DM, Torres AG. Judy BM, et al. Among authors: torres ag. PLoS One. 2012;7(3):e34176. doi: 10.1371/journal.pone.0034176. Epub 2012 Mar 20. PLoS One. 2012. PMID: 22448290 Free PMC article.

6

Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.

AuCoin DP, Reed DE, Marlenee NL, Bowen RA, Thorkildson P, Judy BM, Torres AG, Kozel TR. AuCoin DP, et al. Among authors: torres ag. PLoS One. 2012;7(4):e35386. doi: 10.1371/journal.pone.0035386. Epub 2012 Apr 17. PLoS One. 2012. PMID: 22530013 Free PMC article.

7

Comparative genomics and immunoinformatics approach for the identification of vaccine candidates for enterohemorrhagic Escherichia coli O157:H7.

García-Angulo VA, Kalita A, Kalita M, Lozano L, Torres AG. García-Angulo VA, et al. Among authors: torres ag. Infect Immun. 2014 May;82(5):2016-26. doi: 10.1128/IAI.01437-13. Epub 2014 Mar 4. Infect Immun. 2014. PMID: 24595137 Free PMC article.

8

Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infection.

Massey S, Yeager LA, Blumentritt CA, Vijayakumar S, Sbrana E, Peterson JW, Brasel T, LeDuc JW, Endsley JJ, Torres AG. Massey S, et al. Among authors: torres ag. Sci Rep. 2014 Mar 7;4:4305. doi: 10.1038/srep04305. Sci Rep. 2014. PMID: 24603493 Free PMC article.

9

A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.

Nieves W, Petersen H, Judy BM, Blumentritt CA, Russell-Lodrigue K, Roy CJ, Torres AG, Morici LA. Nieves W, et al. Among authors: torres ag. Clin Vaccine Immunol. 2014 May;21(5):747-54. doi: 10.1128/CVI.00119-14. Epub 2014 Mar 26. Clin Vaccine Immunol. 2014. PMID: 24671550 Free PMC article.

10

A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei.

Gregory AE, Judy BM, Qazi O, Blumentritt CA, Brown KA, Shaw AM, Torres AG, Titball RW. Gregory AE, et al. Among authors: torres ag. Nanomedicine. 2015 Feb;11(2):447-56. doi: 10.1016/j.nano.2014.08.005. Epub 2014 Sep 3. Nanomedicine. 2015. PMID: 25194998 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters